Stockscreener 앱 받기
0.6001
8.52%
-0.0559
시간 외 거래:
.68
0.0799
+13.31%
전일 마감가:
$0.656
열려 있는:
$0.644
하루 거래량:
1.04M
Relative Volume:
5.38
시가총액:
$4.08M
수익:
-
순이익/손실:
$-5.00M
주가수익비율:
-0.7596
EPS:
-0.79
순현금흐름:
$-3.85M
1주 성능:
+21.23%
1개월 성능:
+0.84%
6개월 성능:
-37.36%
1년 성능:
-29.40%
1일 변동 폭
$0.5601
$0.6999
1주일 범위
$0.513
$0.762
52주 변동 폭
$0.4515
$1.87
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
명칭
Protagenic Therapeutics Inc
전화
(212) 994-8200
주소
149 FIFTH AVENUE, NEW YORK
PTIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
0.6001 | 4.08M | 0 | -5.00M | -3.85M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Protagenic Therapeutics Inc 주식(PTIX)의 최신 뉴스
Protagenic Therapeutics faces Nasdaq delisting over equity deficit - Investing.com
PTIX stock touches 52-week low at $0.48 amid market challenges - Investing.com India
Protagenic Therapeutics Receives Delist Determination Letter from Nasdaq - Defense World
Protagenic Therapeutics faces Nasdaq delisting over equity shortfall - Investing.com India
Protagenic Therapeutics faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Australia
ARMISTICE CAPITAL, LLC Acquires New Stake in Protagenic Therapeu - GuruFocus.com
Protagenic Therapeutics Inc. Warrant (PTIXW) Quarterly 10-Q Report - Quartz
Protagenic Therapeutics Inc. (PTIX) Quarterly 10-Q Report - Quartzy
Protagenic Therapeutics Completes Private Placement, Raises $1.275 Million - Defense World
Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million - AccessWire
Protagenic Therapeutics Raises $1.27M in Private Placement with Warrant Offerings | PTIX Stock News - StockTitan
Protagenic Therapeutics Raises $1.275M for Growth Initiatives - TipRanks
Protagenic Therapeutics Secures $1.275M in Private Placement - TipRanks
Protagenic Therapeutics announces $1.275 million stock sale By Investing.com - Investing.com Canada
Protagenic Therapeutics announces $1.275 million stock sale - Investing.com
Protagenic Therapeutics to sell 1.95M shares at 64c in private placement - TipRanks
Protagenic Therapeutics Announces Pricing of Private Placement for Aggregate Gross Proceeds of $1.275 Million - AccessWire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
PTIX stock touches 52-week low at $0.49 amid market challenges By Investing.com - Investing.com South Africa
PTIX stock touches 52-week low at $0.49 amid market challenges - Investing.com Canada
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Short Interest in Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Expands By 3,669.0% - Defense World
The Williams Companies, Inc. (NYSE:WMB) Shares Acquired by Mill Creek Capital Advisors LLC - Defense World
Stephens’s latest rating for PTLO stock - Knox Daily
Petratherm Ltd Reports Key Shareholder Changes - TipRanks
ProSiebenSat.1 Media (OTCMKTS:PBSFY) Shares Up 8.7% - Defense World
A look into Prothena Corporation plc (PRTA)’s deeper side - SETE News
Views of Wall Street’s Leading Experts on Proto Labs Inc - SETE News
Top Wall Street Forecasters Revamp Progress Software Price Expectations Ahead Of Q3 Earnings - Benzinga
Pacer Advisors Inc. Has $74.14 Million Stake in Playtika Holding Corp. (NASDAQ:PLTK) - MarketBeat
Prothena Co. plc (NASDAQ:PRTA) Shares Acquired by Rhumbline Advisers - Defense World
Protagonist Therapeutics Inc [NASDAQ: PTGX] Sees Increase in Stock Value - Knox Daily
Propel Hits 52-Week High on KOHO Link - Baystreet.ca
BOK Financial upgraded, Prosperity Bancshares downgraded at Truist (NASDAQ:BOKF) - Seeking Alpha
Roth/MKM flags Playtika stock’s profitability risks despite new IP additions - Investing.com Australia
Progyny Stock Faces Its Biggest Drop Ever After Losing a Major Client. Why These Analysts Like the Stock. - Barron's
Playtika (NASDAQ:PLTK) Rating Reiterated by Wedbush - Defense World
Progyny price target lowered to $25 from $37 at Cantor Fitzgerald - TipRanks
Acadian Asset Management LLC Sells 27,140 Shares of Proto Labs, Inc. (NYSE:PRLB) - Defense World
Morgan Stanley maintains positive outlook on ProLogis stock By Investing.com - Investing.com Canada
Investors who lost money with shares of Proto Labs, Inc. (NYSE: - openPR
Portage Biotech (PRTG): Wild Ride Continues, But Uncertainty Looms - BP Journal
Headlands Technologies LLC Sells 2,206 Shares of Prothena Co. plc (NASDAQ:PRTA) - Defense World
Analyzing PTC Therapeutics Inc (PTCT) After Recent Trading Activity - Knox Daily
Check Out PTC Therapeutics Inc (PTCT)’s Trade Data Rather Than the Analysts’ Views - SETE News
A better buy-in window may exist right now for Protagonist Therapeutics Inc (PTGX) - SETE News
Bokf Na Raises Position in Kforce Inc. (NASDAQ:KFRC) - Defense World
Why Exicure Shares Are Trading Higher By Over 49%; Here Are 20 Stocks Moving Premarket - Benzinga
Needham & Company LLC Reiterates “Buy” Rating for Kornit Digital (NASDAQ:KRNT) - Defense World
Wall Street analysts’ outlook for Protagenic Therapeutics Inc (PTIX) - SETE News
Protagenic Therapeutics Inc (PTIX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.88%
2.65%
자본화:
|
볼륨(24시간):